![Survodutide Phase 2 Trial Results](/content/images/size/w600/2024/07/boehringer-ingelheim-logo.320x99.png)
chemical:servodutide
Survodutide Phase 2 Trial Results
Survodutide is a dual Glucagon and Glucagon-Like Peptide 1 agonist which interacts with hormone receptors in your body to help reduce food cravings, and encourage weight loss. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out our quick explainer